A

Assessing the complementary information from an increased number of biologically relevant features in liquid biopsy-derived RNA-Seq data

Heliyon, vol. 10, pp. e27360

Abstract

Liquid biopsy-derived RNA sequencing (lbRNA-seq) exhibits significant promise for clinic-oriented cancer diagnostics due to its non-invasiveness and ease of repeatability. Despite substantial advancements, obstacles like technical artefacts and process standardisation impede seamless clinical integration. Alongside addressing technical aspects such as normalising fluctuating low-input material and establishing a standardised clinical workflow, the lack of result validation using independent datasets remains a critical factor contributing to the often low reproducibility of liquid biopsy-detected biomarkers. Considering the outlined drawbacks, our objective was to establish a workflow/methodology characterised by: 1. Harness the rich diversity of biological features accessible through lbRNA-seq data, encompassing a holistic range of molecular and functional attributes. These components are seamlessly integrated via a Machine Learning-based Ensemble Classification framework, enabling a unified and comprehensive analysis of the intricate information encoded within the data. 2. Implementing and rigorously benchmarking intra-sample normalisation methods to heighten their relevance within clinical settings. 3. Thoroughly assessing its efficacy across independent test sets to ascertain its robustness and potential utility. Using ten datasets from several studies comprising three different sources of biological material, we first show that while the best-performing normalisation methods depend strongly on the dataset and coupled Machine Learning method, the rather simple Counts Per Million method is generally very robust, showing comparable performance to cross-sample methods. Subsequently, we demonstrate that the innovative biofeature types introduced in this study, such as the Fraction of Canonical Transcript, harbour complementary information. Consequently, their inclusion consistently enhances prediction power compared to models relying solely on gene expression-based biofeatures. Finally, we demonstrate that the workflow is robust on completely independent datasets, generally from different labs and/or different protocols. Taken together, the workflow presented here outperforms generally employed methods in prediction accuracy and may hold potential for clinical diagnostics application due to its specific design.

Authors 6

  1. Stavros Giannoukakos corresponding

    Universidad de Granada · Parque Tecnológico de la Salud

    Affiliation as printed

    Bioinformatics Laboratory, Biomedical Research Centre (CIBM), PTS, Granada, 18100, Spain

    Department of Genetics, Faculty of Science, University of Granada, Granada, 18071, Spain

    Excellence Research Unit "Modeling Nature" (MNat), University of Granada, Spain

  2. Silvia D’Ambrosi corresponding

    Amsterdam University Medical Centers · Cancer Center Amsterdam · Amsterdam UMC Location Vrije Universiteit Amsterdam

    Affiliation as printed

    Department of Neurosurgery, Cancer Center Amsterdam, Amsterdam UMC, VU University, Amsterdam, 1081HV, the Netherlands

  3. Leiden University

    Affiliation as printed

    Mathematical Institute, Leiden University, Leiden, 2333, CA, the Netherlands

  4. Cancer Center Amsterdam · Amsterdam UMC Location Vrije Universiteit Amsterdam

    Affiliation as printed

    Department of Pathology, Cancer Center Amsterdam, Amsterdam UMC Location Vrije Universiteit Amsterdam, Amsterdam, 1081HV, the Netherlands

  5. Alberto Fernández corresponding

    Universidad de Granada

    Affiliation as printed

    Department of Computer Science and Artificial Intelligence, Andalusian Research Institute in Data Science and Computational Intelligence (DaSCI), University of Granada, Granada, 18071, Spain

  6. Michael Hackenberg corresponding

    Universidad de Granada · Parque Tecnológico de la Salud

    Affiliation as printed

    Bioinformatics Laboratory, Biomedical Research Centre (CIBM), PTS, Granada, 18100, Spain

    Department of Genetics, Faculty of Science, University of Granada, Granada, 18071, Spain

    Excellence Research Unit "Modeling Nature" (MNat), University of Granada, Spain

Cited by 3 stored of 3

3 results

No patents citing this paper on Lens.org (checked 2026-10-11).

References 43